Geode Capital Management
VBIO

Geode Capital Management’s Valion Bio VBIO Stock Holding History

Geode Capital Management’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77.8K Buy
+87,818
New +$89.9K ﹤0.01% 4195
2025
Q1 		– Sell
-2,145
Closed -$12.4K – 4506
2024
Q4 		$12.4K Hold
2,145
– – ﹤0.01% 4425
2024
Q3 		$9.1K Sell
2,145
-29
-1% -$175 ﹤0.01% 4483
2024
Q2 		$14.3K Buy
2,174
+1,410
+185% +$17.8K ﹤0.01% 4509
2024
Q1 		$16K Buy
764
+101
+15% +$2.33K ﹤0.01% 4508
2023
Q4 		$20.6K Buy
+663
New +$19.1K ﹤0.01% 4510

Other funds holding VBIO

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Geode Capital Management's VBIO Position: Q1 2026 in Review

Geode Capital Management opened a new position in Valion Bio (VBIO) in Q1 2026: 87,818 shares worth $77.8K. The stake represents ﹤0.01% of the portfolio and ranks #4195 among its holdings. This is a return to the name: Geode Capital Management previously reported a position in VBIO as recently as Q4 2024.

Geode Capital Management first reported a position in VBIO in Q4 2023 and has held it in 6 quarters since. 9 funds tracked by Wall St. Rank hold VBIO as of Q1 2026.

  • Geode Capital Management held 87,818 shares of Valion Bio worth $77.8K as of Q1 2026.
  • Valion Bio was a new Geode Capital Management position in Q1 2026.
  • Valion Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4195 holding.
  • Geode Capital Management first reported a position in Valion Bio in Q4 2023 and has held it in 6 quarters since.
  • 9 funds tracked by Wall St. Rank held Valion Bio as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.